Indicative Announcement on Convening the 2025 Annual General Meeting
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Indicative Announcement on Convening the 2025 Annual General Meeting
Filed with SSE · · 7 pages · Chinese
Release
Jointown Pharmaceutical Group Co., Ltd. on 6ix
Earlier from Jointown Pharmaceutical
- Announcement on Recognition of Subsidiary as High-tech Enterprise
- Announcement on Subsidiary's Passing GMP Compliance Inspection for Drugs
- Announcement on Holding Subsidiary Certified as High-tech Enterprise
- Report for Q1 2026
- Announcement on Results of Issuing Phase II Ultra-Short-Term Financing Bonds of 2026
Later from Jointown Pharmaceutical
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Subsidiary's Drug Passing Generic Drug Consistency Evaluation
- Announcement on Implementation of Dividend Distribution for 2025
- Announcement on Subsidiary Obtaining Approval for Marketing of Chemical APIs
- Announcement on Issuance of the Phase I Asset-backed Notes for 2026 and Related Party Transactions
Follow Jointown Pharmaceutical into a list and get an email when it puts out news.
Follow Jointown Pharmaceutical